| Durable SARS-CoV-2 B cell immunity after mild or severe disease CO Ogega, NE Skinner, PW Blair, HS Park, K Littlefield, A Ganesan, ... The Journal of clinical investigation 131 (7), 2021 | 103 | 2021 |
| Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses WM Dietz, NEB Skinner, SE Hamilton, MD Jund, SM Heitfeld, AJ Litterman, ... Molecular therapy 21 (8), 1526-1535, 2013 | 65 | 2013 |
| Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation M Kono, N Yoshida, K Maeda, NE Skinner, W Pan, VC Kyttaris, ... Proceedings of the National Academy of Sciences 115 (37), 9288-9293, 2018 | 61 | 2018 |
| Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway J Mariotti, J Foley, K Ryan, N Buxhoeveden, V Kapoor, S Amarnath, ... Blood, The Journal of the American Society of Hematology 112 (12), 4765-4775, 2008 | 48 | 2008 |
| Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection J Mariotti, J Foley, U Jung, T Borenstein, N Kantardzic, S Han, JT Hanson, ... The Journal of Immunology 180 (1), 89-105, 2008 | 43 | 2008 |
| Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2 ME Mossoba, JS Walia, VI Rasaiah, N Buxhoeveden, R Head, C Ying, ... Molecular Therapy 16 (3), 607-617, 2008 | 33 | 2008 |
| IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function L Casciola-Rosen, DR Thiemann, F Andrade, MI Trejo-Zambrano, ... JCI insight 7 (9), 2022 | 30 | 2022 |
| The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection J Mariotti, J Taylor, PR Massey, K Ryan, J Foley, N Buxhoeveden, ... Biology of Blood and Marrow Transplantation 17 (5), 620-631, 2011 | 23 | 2011 |
| Microanatomy in 21 day rat brains exposed prenatally to cocaine DP Buxhoeveden, U Hasselrot, NE Buxhoeveden, RM Booze, ... International journal of developmental neuroscience 24 (5), 335-341, 2006 | 18 | 2006 |
| Sitagliptin results in a decrease of truncated apolipoprotein C1 NEB Skinner, MS Wroblewski, JA Kirihara, GL Nelsestuen, ER Seaquist Diabetes Therapy 6, 395-401, 2015 | 12 | 2015 |
| B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection CO Ogega, NE Skinner, AI Flyak, KE Clark, NL Board, PJ Bjorkman, ... PloS pathogens 18 (1), e1010179, 2022 | 6 | 2022 |
| Broadly neutralizing antibodies against hepatitis C virus: location, location, location NE Skinner, JR Bailey Journal of Hepatology 72 (4), 604-606, 2020 | 5 | 2020 |
| Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery NE Skinner, C Vergara, R El-Diwany, H Paul, A Skaist, SJ Wheelan, ... Viral Immunology 34 (9), 622-631, 2021 | 3 | 2021 |
| Convergent antibody responses are associated with broad neutralization of hepatitis C virus NE Skinner, CO Ogega, N Frumento, KE Clark, H Paul, ... Frontiers in immunology 14, 1135841, 2023 | 2 | 2023 |
| The time is now: A call for renewed support of infectious diseases physician-scientist trainees in the era of coronavirus disease 2019 J Queen, S Karaba, J Albin, A Karaba, J Howard-Anderson, N Skinner, ... The Journal of Infectious Diseases 224 (9), 1452-1454, 2021 | 2 | 2021 |
| Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance CO Ogega, NE Skinner, MV Schoenle, XE Wilcox, N Frumento, DA Wright, ... Immunity 57 (4), 890-903. e6, 2024 | | 2024 |
| Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus NE Skinner, CO Ogega, N Frumento, KE Clark, H Paul, ... Frontiers in immunology 14, 1201033, 2023 | | 2023 |
| Convergent antibody responses associated with broad neutralization of hepatitis C virus and clearance of infection NE Skinner, CO Ogega, N Frumento, KE Clark, S Yegnasubramanian, ... medRxiv, 2021.09. 11.21263416, 2021 | | 2021 |
| Durable SARS-CoV-2 B cell immunity after mild or severe disease (preprint) CO Ogega, NE Skinner, PW Blair, HS Park, K Littlefield, A Ganesan, ... | | 2020 |
| Strategies to improve gene expression and targeting for DNA vaccine development NE Skinner University of Minnesota, 2013 | | 2013 |
